Acarbose

CAS 56180-94-0 10 FDA-DMF suppliersSmall Molecule

Overview

Acarbose is an oral alpha-glucosidase inhibitor used in managing non-insulin-dependent diabetes mellitus. It delays the digestion and absorption of carbohydrates, thereby reducing postprandial blood glucose excursions.

API suppliers (13)

Suppliers of Acarbose backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
  • Bayer AGGermany1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
  • Bayer AGGermany1 active DMF
  • HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTDChina1 active DMF
  • HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTDChina1 active DMF
  • HEBEI HUARONG PHARMACEUTICAL CO LTDChina1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
  • HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTDChina1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
  • HEBEI HUARONG PHARMACEUTICAL CO LTDChina1 active DMF
  • LIVZON NEW NORTH RIVER PHARMACEUTICAL CO LTDChina

Therapeutic areas

DiabetesMetabolic Disorders

Related APIs

Sitagliptin
50 suppliers
Semaglutide
48 suppliers
Dapagliflozin
22 suppliers
Pioglitazone Hydrochloride
15 suppliers
Dulaglutide
1 suppliers
Empagliflozin
42 suppliers
Rosuvastatin
34 suppliers
Linagliptin
29 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo